Detalles de la búsqueda
1.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414060
2.
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
Br J Haematol
; 189(6): 1064-1073, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32130737
3.
Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach.
Br J Clin Pharmacol
; 85(8): 1670-1683, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30933365
4.
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies.
Biomedicines
; 11(2)2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830775
5.
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.
Front Immunol
; 14: 1270843, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795087
6.
C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d.
Front Immunol
; 13: 946522, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36091057
7.
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.
Sci Adv
; 8(39): eabo0514, 2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179026
8.
Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis.
Ther Adv Med Oncol
; 13: 17588359211064653, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987618
9.
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.
Front Immunol
; 12: 767376, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34868021
10.
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Emerg Microbes Infect
; 10(1): 1931-1946, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34538222
11.
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy.
Pharmaceutics
; 13(8)2021 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452230
12.
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
Front Immunol
; 12: 659018, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012444
13.
Adoptive T-cell therapy with CD45RA-depleted donor in the treatment of cytomegalovirus disease in immunocompromised non-transplant patients.
Antivir Ther
; 24(4): 313-319, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30912764
14.
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.
Nat Med
; 25(3): 470-476, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30742120
15.
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
BMJ Open
; 9(9): e030309, 2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31501122
16.
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis.
J Immunother Cancer
; 6(1): 96, 2018 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268156
17.
Targeting NK-cell checkpoints for cancer immunotherapy.
Curr Opin Immunol
; 45: 73-81, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236750
18.
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).
PLoS One
; 12(9): e0185169, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28934318
19.
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
Leuk Lymphoma
; 47(1): 29-37, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16321824
20.
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells.
Oncotarget
; 7(17): 23182-96, 2016 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992239